Compare · head to head
HUTCHMED (China) vs Kissei Pharmaceutical
Kissei Pharmaceutical ranks higher overall — 360 rank 62 vs 27.
Kissei Pharmaceutical leads on Value (61 vs 54), Growth (47 vs 41) and Safety (69 vs 44). The two are close on Quality and Sentiment.
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | Hong Kong SAR China | Japan |
| Sector | Health Care | Health Care |
| Industry | Pharmaceuticals | Pharmaceuticals |
| Size | Medium | Medium |
| ISIN | KYG4672N1198 | JP3240600001 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 27 | 62 |
| Value | 54 | 61 |
| Quality | 42 | 43 |
| Growth | 41 | 47 |
| Safety | 44 | 69 |
| Sentiment | 44 | 41 |
| Quality details | ||
| Profitability | 48 | 40 |
| Cash Truth | 36 | 46 |
HUTCHMED (China) vs Sawai PharmaceuticalHUTCHMED (China) vs Kyowa Hakko KirinHUTCHMED (China) vs Takeda PharmaceuticalHUTCHMED (China) vs Chong Kun DangAdd a third stock →
Full analyses: HUTCHMED (China) · Kissei Pharmaceutical
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100